Novavax High Temp Covid Vaccine Starts Phase 3 Trial, Shares Rise 2,781%
American biotech firm Novavax on Monday launched a late-stage trial of its Covid-19 vaccine in the United States and Mexico.
Michael Ajifowoke
December 29, 2020
